Form 4 for FLNA FILANA THERAPEUTICS, INC.
Accepted 2022-10-03 00:00:00 ET · period of report 2022-10-03 · accession 0001069530-22-000049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-03 | 2022-10-03 | FLNA | FRIEDMANN NADAV | Chief Medical Off, Dir | M - OptEx | $0.95 | +9,376 | 79.9K | +13% | +$8,907 |
| D | 2022-10-03 | 2022-10-03 | FLNA | FRIEDMANN NADAV | Chief Medical Off, Dir | M - OptEx | $0.95 | -9,376 | 40.6K | -19% | -$8,907 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-03 | M | A | 9,376 | $0.95 | 79,910 | D | — | — | (F1) Transaction represents exercise of stock options for cash. |
| 2 | Derivative | Common Stock | 2022-10-03 | M | D | 9,376 | $0.95 | 40,624 | D | $0.95 · 2022-09-14 to 2028-09-14 | 9,376 Common Stock |